No Data
No Data
Trending Stocks Today | Galmed Pharmaceuticals Surges 416.53%
BioNTech Raised to Buy at Jefferies on New Cancer Drug
Merck/Daiichi Sankyo Partnered Lung Cancer Candidate Meets Primary Goal In Late-Stage Study
H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $45
Alphabet To $200? Here Are 10 Top Analyst Forecasts For Monday
Insider Buying: Summit Therapeutics Co-CEO & Executive Chairman Bought US$75m Of Shares
blessings u OP : sold